This segment focuses on the distribution of pharmaceutical products across China, serving hospitals, retail pharmacies, and medical institutions. It involves warehousing, logistics, and supply chain management to ensure timely delivery of medicines. The company leverages its extensive network and infrastructure to provide efficient distribution services. Future opportunities include expanding the distribution network to cover more regions and enhancing logistics capabilities to handle temperature-sensitive products. Partnerships with local import agents are crucial for sourcing and distributing a wide range of pharmaceutical products. This segment is vital for ensuring access to essential medicines for the Chinese population.

This segment is dedicated to the manufacturing and sale of new drugs and finished drugs, including Chinese patent medicines and western medicines. It encompasses research and development, production, and quality control to ensure the efficacy and safety of the manufactured products. The company focuses on producing special drugs and high-end prescription drugs. Future opportunities include investing in R&D to develop innovative medicines and expanding production capacity to meet growing demand. Regulatory compliance and adherence to quality standards are critical aspects of this segment. The company aims to provide customers with professional pharmaceutical products.